This position paper evaluates the distribution alternatives for high-priced drugs on the French retail pharma market, based on:
- Smart Pharma Consulting experience.
- Desk research.
- Interviews of 9 stakeholders (pharma companies, wholesalers and agents).
We have evaluated the pros and cons of direct and indirect distribution for pharma companies, retail pharmacies and patients.
We have also made recommendations regarding distribution in:
- Metropolitan France.
- Overseas France.